[go: up one dir, main page]

BRPI0721238A2 - Método de purificação da apolipoproteina a-1 - Google Patents

Método de purificação da apolipoproteina a-1

Info

Publication number
BRPI0721238A2
BRPI0721238A2 BRPI0721238-0A BRPI0721238A BRPI0721238A2 BR PI0721238 A2 BRPI0721238 A2 BR PI0721238A2 BR PI0721238 A BRPI0721238 A BR PI0721238A BR PI0721238 A2 BRPI0721238 A2 BR PI0721238A2
Authority
BR
Brazil
Prior art keywords
solution
apoa
apolipoprotein
protein
purification method
Prior art date
Application number
BRPI0721238-0A
Other languages
English (en)
Inventor
Kieu Hoang
Bao Xiangfei
Original Assignee
Kieu Hoang
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kieu Hoang filed Critical Kieu Hoang
Publication of BRPI0721238A2 publication Critical patent/BRPI0721238A2/pt
Publication of BRPI0721238B1 publication Critical patent/BRPI0721238B1/pt
Publication of BRPI0721238B8 publication Critical patent/BRPI0721238B8/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/775Apolipopeptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/16Extraction; Separation; Purification by chromatography
    • C07K1/18Ion-exchange chromatography

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Método de purificação da apolipoproteína a-1. Um método de purificação da apoliproteína a-1 incluindo a mistura da fração de plasma iv adquirida pelo método de fracionamento por etanol de cohn com uma solução de uréia de 1-8m para formar uma solução de pré-tratamento de fração iv, carga da solução de pré-tratamento a uma primeira coluna de cromatografia aniônica e posterior eluição com uma solução de uréia de 1-8m para obter uma solução de proteína apoa-1, e carga da solução de proteína apoa-1 em uma segunda coluna de cromatografia aniônica e eluição com uma solução de uréia de 0-1m para obter proteína apoa-1 pura.
BRPI0721238A 2006-12-20 2007-09-19 método de purificação da apolipoproteina a-1 BRPI0721238B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN200610147503A CN100586958C (zh) 2006-12-20 2006-12-20 高纯度载脂蛋白a-i的制备方法
CN200610147503.7 2006-12-20
PCT/US2007/020258 WO2008088403A2 (en) 2006-12-20 2007-09-19 Method of purifying apolipoprotein a-1

Publications (3)

Publication Number Publication Date
BRPI0721238A2 true BRPI0721238A2 (pt) 2015-06-23
BRPI0721238B1 BRPI0721238B1 (pt) 2018-05-29
BRPI0721238B8 BRPI0721238B8 (pt) 2021-05-25

Family

ID=39565747

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0721238A BRPI0721238B8 (pt) 2006-12-20 2007-09-19 método de purificação da apolipoproteina a-1

Country Status (13)

Country Link
EP (1) EP2125861B1 (pt)
JP (1) JP2010513480A (pt)
KR (1) KR101363106B1 (pt)
CN (1) CN100586958C (pt)
AU (1) AU2009202827B8 (pt)
BR (1) BRPI0721238B8 (pt)
CA (1) CA2673516C (pt)
EG (1) EG26516A (pt)
MX (1) MX2009006766A (pt)
MY (1) MY154897A (pt)
RU (1) RU2453555C2 (pt)
TW (1) TWI357347B (pt)
WO (1) WO2008088403A2 (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120177610A1 (en) * 2007-09-19 2012-07-12 Kieu Hoang Manufacturing and Purification Processes of Complex Protein found in Fraction IV to make a separated Apo, Transferrin , and Alpha 1 Anti strepsin (A1AT) or A combined Transferrin / Apo/Human Albumin/A1AT and all new found proteins
CN102127165B (zh) * 2010-01-15 2013-09-04 上海莱士血液制品股份有限公司 一种从血浆组分四沉淀中制备高纯ApoA-I的生产工艺
HUE032560T2 (en) * 2010-06-30 2017-09-28 Csl Ltd Dissolved high density lipoprotein formulation and preparation process
CN102731642B (zh) * 2011-04-14 2014-01-29 上海莱士血液制品股份有限公司 从人血浆组分四沉淀制备高纯Apoa-I的生产工艺
JP5924624B2 (ja) * 2011-04-28 2016-05-25 国立研究開発法人理化学研究所 生物材料を透明化する方法、及びその利用
JP6044900B2 (ja) 2011-05-20 2016-12-14 国立研究開発法人理化学研究所 生物材料用透明化試薬、及びその利用
US20130053551A1 (en) 2011-08-25 2013-02-28 Hoffman-La Roche. Inc. Cation and anion exchange chromatography method
CN103505720A (zh) * 2012-06-30 2014-01-15 复旦大学 载脂蛋白a-i在制备预防和治疗肝病代谢综合征药物中的用途
US9534029B2 (en) 2012-10-03 2017-01-03 Csl Behring Ag Method of purifying proteins
WO2015022883A1 (ja) 2013-08-14 2015-02-19 独立行政法人理化学研究所 光透過性に優れた生物材料を調製するための組成物およびその利用
CN107033237B (zh) * 2017-05-11 2021-07-20 深圳市卫光生物制品股份有限公司 一种人血浆载脂蛋白a-i的分离纯化方法
CN110590935B (zh) * 2019-09-23 2024-01-30 华兰生物工程重庆有限公司 人血白蛋白去除多聚体工艺
CN111153985B (zh) * 2020-01-20 2023-06-13 宁波赛珀生物技术有限公司 血清载脂蛋白a-ii的分离纯化方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1752187A3 (ru) * 1990-12-11 1992-07-30 А.Б.Сигалов Способ делипидировани лиофилизированных липопротеинов высокой плотности из сыворотки крови человека
WO1993000443A1 (en) * 1991-06-26 1993-01-07 Bio-Technology General Corp. Purification of recombinant apolipoprotein e from bacteria
SE9500778D0 (sv) * 1995-03-03 1995-03-03 Pharmacia Ab Process for producing a protein
SE9603068D0 (sv) * 1996-08-23 1996-08-23 Pharmacia & Upjohn Ab Process for purifying a protein
HK1082661A1 (zh) * 2002-07-30 2006-06-16 Esperion Therapeutics Inc. 使用非人类动物载脂蛋白a-i蛋白的方法

Also Published As

Publication number Publication date
WO2008088403A2 (en) 2008-07-24
JP2010513480A (ja) 2010-04-30
CN100586958C (zh) 2010-02-03
AU2009202827A8 (en) 2012-03-08
CA2673516C (en) 2013-10-08
BRPI0721238B1 (pt) 2018-05-29
TW200922675A (en) 2009-06-01
EP2125861A4 (en) 2011-02-02
AU2009202827B8 (en) 2012-03-08
AU2009202827B2 (en) 2011-12-15
RU2453555C2 (ru) 2012-06-20
AU2009202827A1 (en) 2009-08-06
EP2125861A2 (en) 2009-12-02
KR20090116706A (ko) 2009-11-11
MY154897A (en) 2015-08-28
KR101363106B1 (ko) 2014-02-13
CN101205250A (zh) 2008-06-25
WO2008088403A3 (en) 2008-11-06
MX2009006766A (es) 2009-08-12
CA2673516A1 (en) 2008-07-24
EP2125861B1 (en) 2014-07-16
TWI357347B (en) 2012-02-01
BRPI0721238B8 (pt) 2021-05-25
RU2009127816A (ru) 2011-01-27
EG26516A (en) 2014-01-08

Similar Documents

Publication Publication Date Title
BRPI0721238A2 (pt) Método de purificação da apolipoproteina a-1
AR133787A2 (es) Métodos y composiciones que comprenden polipéptidos recombinantes purificados
ECSP099403A (es) Formulacion parenteral del anticuerpo abeta
BR112012009289A8 (pt) Método para purificar um anticorpo anti-il-13 a partir de uma mistura de amostra que compreende um anticorpo anti-il-13 e pelo menos uma proteína de célula hospedeira (hcp)
AR063829A1 (es) Moleculas de enlace de lingo y uso farmaceutico de las mismas
AR072897A1 (es) Composiciones y metodos para anticuerpos que se dirigen a la proteina de complemento c5
BRPI0610197B8 (pt) anticorpo de ligação à esclerostina, processo para a produção do mesmo, composição farmacêutica que compreende o dito anticorpo e vetor de clonagem ou expressão
AR074015A1 (es) Purificacion de proteinas acidas utilizando cromatografia de hidroxiapatita ceramica
BR112012024956A2 (pt) processo para a purificação de uma proteína de fator de crescimento
BR112014012275A2 (pt) purificação de proteína com a utilização de tampão bis-tris
BR112012022223A2 (pt) formulações de proteína concentrada e usos das mesmas
CL2011003122A1 (es) Anticuerpo que se une a la proteina tau fosforilada en la serina 422 (tau ps422), pero no se une a la tau ni al fragmento mcak fosforilado; acido nucleico que lo codifica; metodo de produccion; composicion farmaceutica; y uso util en el tratamiento de una tauopatia, tal como la enfermedad de alzheimer.
NZ598395A (en) Methods for purification of alpha-1-antitrypsin and apolipoprotein A-I
BRPI0911035B8 (pt) ativadores de pirrolidinona glicoquinase
BRPI0715408B8 (pt) Processo para a preparação de 5-(1-alquiltio)alquilpiridinas 2-substituída
BR112013019508A2 (pt) purificação de insulina
BR112012009227A2 (pt) métodos e sistemas para purificar neurotoxina botulínica não complexada
BRPI0517973A (pt) método para purificar o fsh
PE20150720A1 (es) Purificacion de iduronato-2-sulfatasa
EA201491564A1 (ru) Осаждение фракции i-iv-1 иммуноглобулинов из плазмы
EA201001288A1 (ru) Лечение гипертонии 25-гидроксивитамином d3
BRPI0701684A (pt) composição cosmética ou farmacêutica, processo de tratamento cosmético, uso de um composto e composto
ATE443722T1 (de) Peptide und peptidderivate, ihre herstellung sowie ihre verwendung zur herstellung einer therapeutisch und/oder prophylaktisch wirksamen pharmazeutischen zusammensetzung
CL2008003675A1 (es) Compuestos derivados de 5-alquil o alquenil 3-cianopiridinas, procedimiento de preparacion, composicion farmaceutica, util para reducir la actividad incrementada de una enzima en un mamifero, en donde dicha enzima es una proteina quinasa, destinado al tratamiento de la inflamacion, asma, colitis, esclerosis multiple, soriasis, artritis reumatoide.
BRPI0507111A (pt) processo para a preparação de um composto e seus adutos de mannich, composição, concentrado aditivo para combustìveis, e, usos de uma composição e de pelo menos um composto

Legal Events

Date Code Title Description
B15G Petition not considered as such [chapter 15.7 patent gazette]

Free format text: NAO CONHECIDA A PETICAO 016100007277 DE 21/12/2010, EM VIRTUDE DO DISPOSTO ARTIGO 219, INCISO II LPI.

B151 Others concerning applications: resolution cancelled [chapter 15.31 patent gazette]

Free format text: REFERENTE AO DESPACHO 15.7 PUBLICADO NA RPI 2130 DE 01/11/2011.

B15G Petition not considered as such [chapter 15.7 patent gazette]

Free format text: DA PETICAO NO 16100007277 DE 21/12/2010, NAO CONHECIDA A GUIA 221010949343 DE 20/12/2010, REFERENTE A TAXA DE RESTAURACAO EM VIRTUDE DO DISPOSTO ARTIGO 219, INCISO II DA LPI.

B65X Notification of requirement for priority examination of patent application
B65Z Priority examination of the patent application refused (request does not comply with dec. 132/06 of 20061117)

Free format text: NEGADO O EXAME PRIORITARIO DO PEDIDO DE PATENTE UMA VEZ QUE NAO FOI ATENDIDO O DISPOSTO NO ART. 6O, I DA RESOLUCAO 068/13.

B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 29/05/2018, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 19/09/2007 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 17A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2793 DE 16-07-2024 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.